N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease

N-methyl-D-aspartate (NMDA) receptors are the major mediator of excitotoxicity. Although physiological activation of the NMDA receptor is necessary for cell survival, overactivation is a signal for cell death. Several pathways are activated through NMDA receptor stimulation, most of which can contribute to excitotoxicity. These include events leading to mitochondrial dysfunction, activation of calcium-dependent enzymes, and activation of mitogen-activated protein kinase pathways. Understanding the role of these mechanisms is important in developing agents that block excitotoxicity without inhibiting functions necessary for survival. NMDA receptor subtypes may be responsible for mediating separate pathways, and subtype-specific inhibition has shown promising results in some neurological models. This review examines the roles of NMDA receptor subtypes in excitotoxicity and neurological disorders.

[1]  Won-Seok Choi,et al.  Phosphorylation of p38 MAPK Induced by Oxidative Stress Is Linked to Activation of Both Caspase-8- and -9-mediated Apoptotic Pathways in Dopaminergic Neurons* , 2004, Journal of Biological Chemistry.

[2]  D. Standaert,et al.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease. , 2004, Pharmacology & therapeutics.

[3]  M. Fehlings,et al.  Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN , 2004, The Journal of Neuroscience.

[4]  E. Kandel,et al.  Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.

[5]  Michael W. Salter,et al.  Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.

[6]  T. Babb,et al.  Mechanisms of epileptogenicity in cortical dysplasias , 2004, Neurology.

[7]  Sheng-tian Li,et al.  Critical Role of Calpain-mediated Cleavage of Calcineurin in Excitotoxic Neurodegeneration* , 2004, Journal of Biological Chemistry.

[8]  R. Rissman,et al.  Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology , 2004, Neurobiology of Disease.

[9]  H. Tse,et al.  Structure–activity analysis of a novel NR2C/NR2D‐preferring NMDA receptor antagonist: 1‐(phenanthrene‐2‐carbonyl) piperazine‐2,3‐dicarboxylic acid , 2004, British journal of pharmacology.

[10]  K. Hoyt,et al.  CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice , 2004, The Journal of Neuroscience.

[11]  M. MacDonald,et al.  Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells* , 2003, Journal of Biological Chemistry.

[12]  R. Neumar,et al.  Selective Activation Induced Cleavage of the NR2B Subunit by Calpain , 2003, The Journal of Neuroscience.

[13]  A. Periasamy,et al.  Nitric-oxide-induced depolarization of neuronal mitochondria: implications for neuronal cell death , 2003, Molecular and Cellular Neuroscience.

[14]  L. Raymond,et al.  Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease , 2003, Neurobiology of Aging.

[15]  E. Ziff,et al.  NMDA receptor regulation of nNOS phosphorylation and induction of neuron death , 2003, Neurobiology of Aging.

[16]  Yehezkel Ben-Ari,et al.  The NMDA Receptor Is Coupled to the ERK Pathway by a Direct Interaction between NR2B and RasGRF1 , 2003, Neuron.

[17]  E. Nagata,et al.  Akt as a mediator of cell death , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Feldman,et al.  Treatment of Alzheimer's disease; current status and new perspectives , 2003, The Lancet Neurology.

[19]  C. Parsons,et al.  Expression of Polyglutamine-expanded Huntingtin Induces Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptors* , 2003, Journal of Biological Chemistry.

[20]  G. Fiskum,et al.  Mitochondrial Mechanisms of Neural Cell Death and Neuroprotective Interventions in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[21]  H. Tokumitsu,et al.  Post-synaptic density-95 promotes calcium/calmodulin-dependent protein kinase II-mediated Ser847 phosphorylation of neuronal nitric oxide synthase. , 2003, The Biochemical journal.

[22]  P. Spano,et al.  Regulation of Dopamine D1 Receptor Trafficking and Desensitization by Oligomerization with Glutamate N-Methyl-D-aspartate Receptors* , 2003, Journal of Biological Chemistry.

[23]  W. Löscher,et al.  N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy , 2003, Neuroscience.

[24]  K. Storey,et al.  Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress , 2003, Journal of Experimental Biology.

[25]  M. Billingsley,et al.  Calcium-dependent interaction of calcineurin with bcl-2 in neuronal tissue , 2003, Neuroscience.

[26]  D. Chuang,et al.  Lithium‐induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N‐methyl‐D‐aspartate receptor‐mediated excitotoxicity , 2003, FEBS letters.

[27]  S. J. Tavalin,et al.  Mapping the Protein Phosphatase-2B Anchoring Site on AKAP79 , 2002, The Journal of Biological Chemistry.

[28]  Yitao Liu,et al.  Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.

[29]  M. di Luca,et al.  Lack of PSD‐95 drives hippocampal neuronal cell death through activation of an αCaMKII transduction pathway , 2002, The European journal of neuroscience.

[30]  R. Malinow,et al.  Ras and Rap Control AMPA Receptor Trafficking during Synaptic Plasticity , 2002, Cell.

[31]  R. V. Omkumar,et al.  Sequence determinants on the NR2A and NR2B subunits of NMDA receptor responsible for specificity of phosphorylation by CaMKII. , 2002, Biochimica et biophysica acta.

[32]  A. A. Parsons,et al.  The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. , 2002, European journal of pharmacology.

[33]  T. Akiyama,et al.  SPAL, a Rap‐specific GTPase activating protein, is present in the NMDA receptor‐PSD‐95 complex in the hippocampus , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  G. Avanzini,et al.  αCaMKII and NMDA‐Receptor Subunit Expression in Epileptogenic Cortex from Human Periventricular Nodular Heterotopia , 2002, Epilepsia.

[35]  H. Bading,et al.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.

[36]  T. Shimahara,et al.  Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus , 2002, Neurobiology of Learning and Memory.

[37]  Y. Auberson,et al.  5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. , 2002, Bioorganic & medicinal chemistry letters.

[38]  M. Vemuri,et al.  Calpain activation and α-spectrin cleavage in rat brain by ethanol , 2002, Neuroscience Letters.

[39]  L. Raymond,et al.  Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease , 2002, Neuron.

[40]  D. Lynch,et al.  Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. , 2002, The Journal of pharmacology and experimental therapeutics.

[41]  T. Bliss,et al.  Brain-Derived Neurotrophic Factor Induces Long-Term Potentiation in Intact Adult Hippocampus: Requirement for ERK Activation Coupled to CREB and Upregulation of Arc Synthesis , 2002, The Journal of Neuroscience.

[42]  Hiroto Takahashi,et al.  Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits , 2002, Nature.

[43]  Hans Forssberg,et al.  Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Tsien,et al.  Differential effects of enrichment on learning and memory function in NR2B transgenic mice , 2001, Neuropharmacology.

[45]  D. Lynch,et al.  NMDA receptor pharmacology: perspectives from molecular biology. , 2001, Current drug targets.

[46]  M. Sheng,et al.  Regulation of Dendritic Spine Morphology by SPAR, a PSD-95-Associated RapGAP , 2001, Neuron.

[47]  F. Castellino,et al.  The Amino Acid Residue at Sequence Position 5 in the Conantokin Peptides Partially Governs Subunit-selective Antagonism of RecombinantN-Methyl-d-aspartate Receptors* , 2001, The Journal of Biological Chemistry.

[48]  Paul De Koninck,et al.  Interaction with the NMDA receptor locks CaMKII in an active conformation , 2001, Nature.

[49]  G. Liao,et al.  Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. , 2001, Molecular pharmacology.

[50]  I. Módy,et al.  Kindling induces transient NMDA receptor-mediated facilitation of high-frequency input in the rat dentate gyrus. , 2001, Journal of neurophysiology.

[51]  M. di Luca,et al.  Hippocampal Synaptic Plasticity Involves Competition between Ca2+/Calmodulin-Dependent Protein Kinase II and Postsynaptic Density 95 for Binding to the NR2A Subunit of the NMDA Receptor , 2001, The Journal of Neuroscience.

[52]  S. Kassis,et al.  SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.

[53]  Michael R. Hayden,et al.  Mutant Huntingtin Enhances Excitotoxic Cell Death , 2001, Molecular and Cellular Neuroscience.

[54]  S. Venneti,et al.  NMDA and Glutamate Evoke Excitotoxicity at Distinct Cellular Locations in Rat Cortical Neurons In Vitro , 2000, The Journal of Neuroscience.

[55]  R. Tremblay,et al.  Transient NMDA Receptor Inactivation Provides Long-Term Protection to Cultured Cortical Neurons from a Variety of Death Signals , 2000, The Journal of Neuroscience.

[56]  S. Donevan,et al.  Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. , 2000, Molecular pharmacology.

[57]  J. Prehn,et al.  Delayed Mitochondrial Dysfunction in Excitotoxic Neuron Death: Cytochrome c Release and a Secondary Increase in Superoxide Production , 2000, The Journal of Neuroscience.

[58]  S. Larner,et al.  p38 Map Kinase Mediates Bax Translocation in Nitric Oxide–Induced Apoptosis in Neurons , 2000, The Journal of cell biology.

[59]  G. Cole,et al.  Activation of Calpain I Converts Excitotoxic Neuron Death into a Caspase-independent Cell Death* , 2000, The Journal of Biological Chemistry.

[60]  M. Baudry,et al.  Calpain-mediated degradation of PSD-95 in developing and adult rat brain , 2000, Neuroscience Letters.

[61]  M. Bennett,et al.  Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Shea,et al.  Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC , 1999, Brain Research.

[63]  D. Fass,et al.  Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca2+]i increases and NMDA receptor mRNA levels , 1999, Brain Research.

[64]  S. R. Datta,et al.  Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. , 1999, Science.

[65]  C. Hisatsune,et al.  Phosphorylation–dependent interaction of the N‐methyl‐ d‐aspartate receptor ε2 subunit with phosphatidylinositol 3‐kinase , 1999 .

[66]  L. Raymond,et al.  Subtype-Dependence of NMDA Receptor Channel Open Probability , 1999, The Journal of Neuroscience.

[67]  M. di Luca,et al.  αCaMKII binding to the C‐terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation , 1999, FEBS letters.

[68]  J. Macdonald,et al.  Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. , 1999, Science.

[69]  G. Westbrook,et al.  The Incorporation of NMDA Receptors with a Distinct Subunit Composition at Nascent Hippocampal Synapses In Vitro , 1999, The Journal of Neuroscience.

[70]  L. Raymond,et al.  Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin , 1999, Journal of neurochemistry.

[71]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[72]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[73]  T. Peng,et al.  Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. , 1998, Molecular pharmacology.

[74]  M. Kennedy,et al.  A Synaptic Ras-GTPase Activating Protein (p135 SynGAP) Inhibited by CaM Kinase II , 1998, Neuron.

[75]  R. Huganir,et al.  SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein Family , 1998, Neuron.

[76]  S. Vicini,et al.  Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons , 1998, The Journal of physiology.

[77]  K. Mikoshiba,et al.  Phosphorylation-dependent Regulation ofN-Methyl-d-aspartate Receptors by Calmodulin* , 1997, The Journal of Biological Chemistry.

[78]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[79]  D. Bredt,et al.  Cloning and Characterization of Postsynaptic Density 93, a Nitric Oxide Synthase Interacting Protein , 1996, The Journal of Neuroscience.

[80]  J. Penney,et al.  Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. , 1996, Brain research. Molecular brain research.

[81]  A. F. Schinder,et al.  Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.

[82]  R. Huganir,et al.  SAP102, a Novel Postsynaptic Protein That Interacts with NMDA Receptor Complexes In Vivo , 1996, Neuron.

[83]  M. Sheng,et al.  Heteromultimerization and NMDA Receptor-Clustering Activity of Chapsyn-110, a Member of the PSD-95 Family of Proteins , 1996, Neuron.

[84]  T. Dawson,et al.  Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[85]  M. Sheng,et al.  Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[86]  J. Greene,et al.  Manipulation of Membrane Potential Modulates Malonate‐Induced Striatal Excitotoxicity In Vivo , 1996, Journal of neurochemistry.

[87]  M. Goldberg,et al.  Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[88]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.

[89]  B. Sakmann,et al.  Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.

[90]  S. Snyder,et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[91]  I. Módy,et al.  Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[92]  R. Siman,et al.  Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[93]  D. Choi Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[94]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.

[95]  William Holmes,et al.  Models of Calmodulin Trapping and CaM Kinase II Activation in a Dendritic Spine , 2004, Journal of Computational Neuroscience.

[96]  A. A. Parsons,et al.  The selective p 38 inhibitor SB-239063 protects primary neurons from 2 mild to moderate excitotoxic injury 3 , 2002 .

[97]  M. Vemuri,et al.  Calpain activation and alpha-spectrin cleavage in rat brain by ethanol. , 2002, Neuroscience letters.

[98]  C. Hisatsune,et al.  Phosphorylation-dependent interaction of the N-methyl-D-aspartate receptor epsilon 2 subunit with phosphatidylinositol 3-kinase. , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[99]  T. Dawson,et al.  Nitric oxide in neurodegeneration. , 1998, Progress in brain research.

[100]  Jianhong Luo,et al.  The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). , 1997, Molecular pharmacology.

[101]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.